We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Up 18% and 16% in February! Are these 2 blue chips the best stocks to buy in March too?

Harvey Jones is looking for the best stocks to buy over the next few weeks and wonders whether there’s an opportunity in two recent FTSE 100 winners.

| More on:
Business manager working at a pub doing the accountancy and some paperwork using a laptop computer

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

The results are in and the two best FTSE 100 stocks to buy in February were drugs maker GSK (LSE: GSK) and grocery chain Tesco (LSE: TSCO). Both are viewed as solid blue chips, offering steady price growth and a reliable stream of dividends. They’re not expected to shoot the lights out but they gave it a good try last month, climbing 18% and 16% respectively. They’ve been strong over 12 months too, up 48% and 28%, with dividends on top. Can they maintain momentum in March?

I should note that one FTSE 100 stock did outperform them both. Fund manager Schroders ended February 28% higher. That’s because it has been taken over by US institutional fund manager in a £9.9bn deal, which will take it private.

Should you buy GSK shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

GSK shares fulfilled my hopes

I’m especially pleased with the GSK bounce, having bought the stock 18 months ago when the P/E was around eight. My shares dipped shortly after I bought them, but now I’m nicely in the black. Can it deliver more?

2025 profits, announced on 4 February, saw turnover rise 4% to £32.6bn, with core operating profit up 8% to £9.7bn. Total operating profit nearly doubled to £7.93bn. However, the board warned that growth would slow to between 3% and 5% in 2026. This is due to the expiry of an HIV drug patent and a US pricing deal with the Trump administration. GSK makes more than half its profits in the US.

Risks remain, including US tariffs, and the perennial challenge of slow and costly drug development and potential litigation. There’s also the need to replenish its long-term treatment pipeline. Healthcare is often seen as a defensive sector, but it’s far from risk-free.

Today, GSK is more expensive than when I bought it, with a P/E of 12.6 and a trailing yield of about 3%. I suspect the shares may slow from here but for investors wanting long-term exposure to a key sector, I think it’s worth considering in March.

Tesco has had a good run

Tesco is pricier, with a P/E of 17.5. This is hardly surprising given the shares have flown 115% over five years, with dividends on top. The UK grocer has cemented its market-leading position, with a 28.7% share versus Sainsbury’s at 16.2%. It has shrugged off Aldi and Lidl while absorbing higher employer’s National Insurance and two big living wage hikes.

Food price inflation is now easing, which should help margins and demand. Christmas was a tad disappointing, though. Underlying sales growth slowed, though market share still managed to hit a decade high of 29.4%. Wholesale subsidiary arm Booker is also struggling, but Tesco still expects annual adjusted operating profit at the top of its guidance range of £2.9bn to £3.1bn.

Again, I think Tesco is worth considering with a long-term view. I also think it could slow in the shorter run. Investor expectations are high, judging by that valuation. And while the cost-of-living crisis is easing, shoppers are still under the cosh.

However, rather than chasing past winners, I’ll continue my search for the best FTSE 100 stocks to buy in March. I’ve got a feeling there’s more excitement elsewhere on the index. Bring it on.

Harvey Jones has positions in GSK. The Motley Fool UK has recommended GSK, Schroders Plc, and Tesco Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Tree lined "tunnel" in the English countryside of West Sussex in autumn
Investing Articles

3 UK shares to consider holding in a Stocks and Shares ISA for a decade

Mark Hartley explains why he thinks these three stocks would make great additions to a long-term Stocks and Shares ISA…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

Where should value investors look for stocks in June?

Value investors looking for stocks to buy might be uneasy with artificial intelligence. But other industries look much more attractive…

Read more »

Investing Articles

The latest broker outlooks on Greggs shares look wacky, so what’s happening?

Analyst price targets for Greggs shares are creating some mixed sentiments on where the high-street baker might go next in…

Read more »

Caerphilly Castle, and reflection in the moat.
Investing Articles

2 FTSE 100 dividend stocks that stand out for shareholder returns

Andrew Mackie highlights two FTSE 100 dividend stocks where disciplined capital allocation could continue driving shareholder returns.

Read more »

Senior Adult Black Female Tourist Admiring London
Investing Articles

Just 9% of us can expect a ‘comfortable’ retirement! Could UK shares be the answer?

Millions of Brits could miss out on the retirement of their dreams. Might they avoid this by investing in UK…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

3 passive income shares to consider buying for a 7% yield

Harvey Jones picks out three UK income shares that offer terrific dividends and are trading at tempting valuations. None of…

Read more »

Businessman hand stacking up arrow on wooden block cubes
Investing Articles

How much just £4,160 invested in Rolls-Royce shares 5 years ago is worth now

Rolls-Royce shares have been on a remarkable run of late. Ken Hall takes a look at the key drivers and…

Read more »

Cropped shot of an affectionate young couple posing with a bunch of flowers in their kitchen on their anniversary
Investing Articles

The FTSE 100’s Howden Joinery just made a bold move — should investors care?

Andrew Mackie looks at the FTSE 100’s Howden Joinery and its move into online kitchens, asking what the acquisition means…

Read more »